F-group (family)
10.2.1.69 Rhv_5
Ligands and drugs
398
Member domains
119
with ligand contacts (≤ 4 Å)
29.9% of members
94
with DrugDomain annotations
23.6% of members
43
with a DrugBank compound
10.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 10.2.1.69 belongs to X-group 10 jelly-roll, which binds 8.5 ligand superclasses per 20 proteins, broader than 66% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03796 | PLM | Palmitic Acid | 12 |
| DB05105 | W11 | Pleconaril | 6 |
| DB03017 | DAO | Lauric acid | 5 |
| DB03193 | STE | Stearic acid | 4 |
| DB08231 | MYR | Myristic acid | 4 |
| DB08726 | W71 | Disoxaril | 3 |
| DB00143 | GSH | Glutathione | 2 |
| DB00145 | GLY | Glycine | 2 |
| DB00151 | CYS | Cysteine | 2 |
| DB00131 | AMP | Adenosine phosphate | 1 |
| DB00142 | GLU | Glutamic acid | 1 |
| DB03203 | SQS | Sphingosine | 1 |
| DB03600 | DKA | Capric acid | 1 |
| DB08713 | W01 | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL | 1 |
| DB08714 | W02 | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL | 1 |
| DB08715 | W03 | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SPH | SPHINGOSINE | 58 |
| PLM | PALMITIC ACID | 12 |
| Kmetal | POTASSIUM ION | 11 |
| NAmetal | SODIUM ION | 11 |
| ZNmetal | ZINC ION | 8 |
| W11 | 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE | 6 |
| DAO | LAURIC ACID | 5 |
| STE | STEARIC ACID | 5 |
| CL | CHLORIDE ION | 4 |
| MYR | MYRISTIC ACID | 4 |
| W71 | 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE | 3 |
| 906 | 1-(2-aminopyridin-4-yl)-3-[(3S)-5-{4-[(E)-(ethoxyimino)methyl]phenoxy}-3-methylpentyl]imidazolidin-2-one | 2 |
| CYS | CYSTEINE | 2 |
| FHK | 4-[[4-[1,3-bis(oxidanylidene)isoindol-2-yl]phenyl]sulfonylamino]benzoic acid | 2 |
| GLY | GLYCINE | 2 |
| GSH | Glutathione | 2 |
| YM2 | 1-[(3S)-5-[4-[(E)-ETHOXYIMINOMETHYL]PHENOXY]-3-METHYL-PENTYL]-3-PYRIDIN-4-YL-IMIDAZOLIDIN-2-ONE | 2 |
| 7J5 | 4-[3-[(3s)-5-[4-[(e)-ethoxyiminomethyl]phenoxy]-3-methyl-pentyl]-2-oxidanylidene-imidazolidin-1-yl]pyridine-2-carboxamide | 1 |
| 7VR | 4-((5-(2-oxo-3-(pyridin-4-yl)imidazolidin-1-yl)pentyl)oxy)benzaldehyde O-ethyl oxime | 1 |
| A1AIC | (4M)-4-[1-(2-methoxyethyl)-1H-pyrazol-4-yl]-N-({4-[(propan-2-yl)oxy]phenyl}methyl)quinolin-8-amine | 1 |